Infrequent "chronic lymphocytic leukemia-specific" immunoglobulin stereotypes in aged individuals with or without low-count monoclonal B-cell lymphocytosis

Andreas Agathangelidis; Chrysi Galigalidou; Lydia Scarfò; Theodoros Moysiadis; Alessandra Rovida; Maria Gounari; Fotis Psomopoulos; Pamela Ranghetti; Alex Galanis; Frederic Davi; Kostas Stamatopoulos; Anastasia Chatzidimitriou; Paolo Ghia

doi:10.3324/haematol.2020.247908

Infrequent "chronic lymphocytic leukemia-specific" immunoglobulin stereotypes in aged individuals with or without low-count monoclonal B-cell lymphocytosis

Haematologica. 2021 Apr 1;106(4):1178-1181. doi: 10.3324/haematol.2020.247908.

Affiliations

¹ Division of Experimental Oncology, Università Vita-Salute, Ospedale San Raffaele, Milan, Italy.
² Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece.
³ Dept. of Molecular Biology and Genetics, Democritus University of Thrace, Alexandroupolis, Greece.
⁴ Biological Hematology, Hopital Pitié-Salpetriere, Sorbonne Université, Paris, France.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Aged
B-Lymphocytes
Humans
Immunoglobulins
Leukemia, Lymphocytic, Chronic, B-Cell* / diagnosis
Lymphocyte Count
Lymphocytosis* / diagnosis

Substances

Immunoglobulins

Grants and funding

Funding: this project received funding from the Hellenic Foundation for Research and Innovation (HFRI) and the General Secretariat for Research and Technology (GSRT), under grant agreement n. 336 (Project CLLon); the TRANSCAN-2 Joint Transnational Call for Proposals 2014 (JTC 2014) by the European Commission/DG Research and Innovation; the TRANSCAN-2: Employing next-generation sequencing technology for improved, non-invasive early detection, staging and prediction of progression in lymphoma patients (NOVEL/MIS 5041673); the project “KRIPIS II ODYSSEUS” funded by the Operational Programme "Competitiveness, Entrepreneurship and Innovation" (NSRF 2014-2020) and cofinanced by Greece and the European Union (European Regional Development Fund); the Italian Association for Cancer Research (AIRC, Special Program on Metastasis, 5 per mille #21198 to PG); PRIN 2015ZMRFEA, Italian Ministry of University and Research - MIUR, Roma, Italy; open access project, ID number LM2011020, funded by the Ministry of Education, Youth and Sports of the Czech Republic under the activity “Projects of major infrastructures for research, development and innovations”; the Greek Precision Medicine Network, a mission of the Research and Innovation sector of the Ministry of Education, Research and Religious Affairs of Greece; the Asklepios Grant Programme grant from Gilead Hellas. MG is recipient of a Marie Sklodowska-Curie individual fellowship (grant agreement n. 796491), funded by the European Union’s Horizon 2020 research and innovation programme.